| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PNAS..112E.297H |
| P356 | DOI | 10.1073/PNAS.1424028112 |
| P932 | PMC publication ID | 4311831 |
| P698 | PubMed publication ID | 25564661 |
| P5875 | ResearchGate publication ID | 270661295 |
| P50 | author | Ronald M. Evans | Q969420 |
| P2093 | author name string | Ruth T Yu | |
| Michael Downes | |||
| Nasun Hah | |||
| Chris Benner | |||
| Ling-Wa Chong | |||
| P2860 | cites work | Highly conserved non-coding sequences are associated with vertebrate development | Q21092819 |
| A large fraction of extragenic RNA pol II transcription sites overlap enhancers | Q21145794 | ||
| Discovery of active enhancers through bidirectional expression of short transcripts | Q21184027 | ||
| Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities | Q24617969 | ||
| Histone H3K27ac separates active from poised enhancers and predicts developmental state | Q24628758 | ||
| The Mediator complex: a master coordinator of transcription and cell lineage development | Q26859539 | ||
| Enhancer RNAs and regulated transcriptional programs | Q26865277 | ||
| Fast gapped-read alignment with Bowtie 2 | Q27860699 | ||
| Topological domains in mammalian genomes identified by analysis of chromatin interactions | Q28264221 | ||
| Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters | Q28302903 | ||
| Super-enhancers in the control of cell identity and disease | Q28661442 | ||
| A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression | Q29614326 | ||
| A unique chromatin signature uncovers early developmental enhancers in humans | Q29614327 | ||
| Widespread transcription at neuronal activity-regulated enhancers | Q29614330 | ||
| Master transcription factors and mediator establish super-enhancers at key cell identity genes | Q29618062 | ||
| Anti-diabetic rosiglitazone remodels the adipocyte transcriptome by redistributing transcription to PPARγ-driven enhancers | Q33600223 | ||
| Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. | Q33601156 | ||
| Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation | Q33665345 | ||
| lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. | Q33666551 | ||
| Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes | Q33770661 | ||
| The active enhancer network operated by liganded RXR supports angiogenic activity in macrophages. | Q33917441 | ||
| Enhancer function: new insights into the regulation of tissue-specific gene expression | Q34025898 | ||
| Transcriptional regulation and its misregulation in disease. | Q34036033 | ||
| Transient estrogen receptor binding and p300 redistribution support a squelching mechanism for estradiol-repressed genes | Q34131693 | ||
| Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA | Q34185076 | ||
| Noncoding transcription at enhancers: general principles and functional models | Q34294940 | ||
| eRNAs are required for p53-dependent enhancer activity and gene transcription | Q34319965 | ||
| Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation | Q34348069 | ||
| Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants | Q34377776 | ||
| Transcription factor cooperativity in early adipogenic hotspots and super-enhancers. | Q34421229 | ||
| Long non-coding RNAs and enhancers | Q34627040 | ||
| Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions | Q35145499 | ||
| Functional and mechanistic diversity of distal transcription enhancers | Q37091409 | ||
| Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. | Q37340291 | ||
| The emerging roles of eRNAs in transcriptional regulatory networks. | Q37681034 | ||
| Selective transcription in response to an inflammatory stimulus | Q37715321 | ||
| Enhancer RNAs: the new molecules of transcription | Q38183529 | ||
| A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells | Q39546838 | ||
| Bcl-6 and NF-kappaB cistromes mediate opposing regulation of the innate immune response. | Q41193370 | ||
| NF-κB directs dynamic super enhancer formation in inflammation and atherogenesis | Q41971115 | ||
| Enhancer transcripts mark active estrogen receptor binding sites | Q42597586 | ||
| Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. | Q42972194 | ||
| Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. | Q43141233 | ||
| NF-κB is 25. | Q46097461 | ||
| Seq-ing LPS-induced enhancers | Q46153218 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | E297-302 | |
| P577 | publication date | 2015-01-06 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs | |
| P478 | volume | 112 |
| Q39207675 | A Novel Epi-drug Therapy Based on the Suppression of BET Family Epigenetic Readers |
| Q39199057 | A Phase Separation Model for Transcriptional Control. |
| Q99365593 | Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer |
| Q33574512 | Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate Cancer |
| Q40795476 | Acute TNF-induced repression of cell identity genes is mediated by NFκB-directed redistribution of cofactors from super-enhancers |
| Q37657825 | Altered enhancer transcription underlies Huntington's disease striatal transcriptional signature |
| Q26796369 | Architectural and Functional Commonalities between Enhancers and Promoters |
| Q52697946 | BET Family Protein BRD4: An Emerging Actor in NFκB Signaling in Inflammation and Cancer. |
| Q36906022 | BET Inhibition Attenuates Helicobacter pylori-Induced Inflammatory Response by Suppressing Inflammatory Gene Transcription and Enhancer Activation. |
| Q40230617 | Brd4 modulates the innate immune response through Mnk2-eIF4E pathway-dependent translational control of IκBα. |
| Q41851056 | Causal role of histone acetylations in enhancer function |
| Q58761894 | Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression |
| Q38858540 | Cofactor squelching: Artifact or fact? |
| Q34468271 | Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers |
| Q89989911 | Coordinated demethylation of H3K9 and H3K27 is required for rapid inflammatory responses of endothelial cells |
| Q37517522 | DNA Hypomethylation in Intragenic and Intergenic Enhancer Chromatin of Muscle-Specific Genes Usually Correlates with their Expression |
| Q38807143 | Developmental Control of NRAMP1 (SLC11A1) Expression in Professional Phagocytes |
| Q93016720 | Diversity and Emerging Roles of Enhancer RNA in Regulation of Gene Expression and Cell Fate |
| Q96230995 | Enhancer RNAs are an important regulatory layer of the epigenome |
| Q92493381 | Enhancer and super-enhancer: Positive regulators in gene transcription |
| Q49607235 | Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis. |
| Q34046402 | Enhancers as non-coding RNA transcription units: recent insights and future perspectives |
| Q38777244 | Epigenetic Regulation of Monocyte and Macrophage Function |
| Q92476124 | Epigenetic regulation of IFITM1 expression in lipopolysaccharide-stimulated human mesenchymal stromal cells |
| Q38733315 | Epigenetic regulation of cardiac fibrosis |
| Q92659344 | Epigenetic regulation of the innate immune response to infection |
| Q91871661 | From Super-Enhancer Non-coding RNA to Immune Checkpoint: Frameworks to Functions |
| Q39209007 | Functional Enhancers As Master Regulators of Tissue-Specific Gene Regulation and Cancer Development |
| Q39088450 | Genome-Wide Approaches to Defining Macrophage Identity and Function |
| Q98611511 | H. pylori infection confers resistance to apoptosis via Brd4-dependent BIRC3 eRNA synthesis |
| Q33593001 | Higher-Order Chromatin Regulation of Inflammatory Gene Expression |
| Q39031414 | Immune disease-associated variants in gene enhancers point to BET epigenetic mechanisms for therapeutic intervention |
| Q64098224 | Integrative modeling reveals key chromatin and sequence signatures predicting super-enhancers |
| Q64261629 | LRH1-driven transcription factor circuitry for hepatocyte identity: Super-enhancer cistromic analysis |
| Q38716426 | Long noncoding RNAs as Organizers of Nuclear Architecture |
| Q38292180 | Loss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes |
| Q35852366 | Motif signatures in stretch enhancers are enriched for disease-associated genetic variants |
| Q37536837 | Multiple-level validation identifies PARK2 in the development of lung cancer and chronic obstructive pulmonary disease |
| Q93065106 | NET-CAGE characterizes the dynamics and topology of human transcribed cis-regulatory elements |
| Q58713866 | Nascent RNA sequencing analysis provides insights into enhancer-mediated gene regulation |
| Q42776375 | Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington's disease mice |
| Q36179241 | New roles for DNA cytosine modification, eRNA, anchors, and superanchors in developing B cell progenitors |
| Q91826055 | Oncogenic seRNA functional activation: a novel mechanism of tumorigenesis |
| Q94550585 | Oncogenic super-enhancer formation in tumorigenesis and its molecular mechanisms |
| Q38852230 | Quantification of nascent transcription by bromouridine immunocapture nuclear run-on RT-qPCR. |
| Q90747992 | RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation |
| Q38701309 | Recognition of long-range enhancer-promoter interactions by adding genomic signatures of segmented regulatory regions |
| Q47660875 | Super enhancers - new analyses and perspectives on the low hanging fruit |
| Q90017708 | Super-enhancer function and its application in cancer targeted therapy |
| Q37343021 | Superenhancer reprogramming drives a B-cell-epithelial transition and high-risk leukemia |
| Q47755605 | TBX4 is involved in the super-enhancer-driven transcriptional programs underlying features specific to lung fibroblasts. |
| Q42293418 | TT-seq captures enhancer landscapes immediately after T-cell stimulation. |
| Q64075187 | The Association Between Vitamin D and Multiple Sclerosis Risk: 1,25(OH)D Induces Super-Enhancers Bound by VDR |
| Q49393104 | The Transcription Factor STAT6 Mediates Direct Repression of Inflammatory Enhancers and Limits Activation of Alternatively Polarized Macrophages. |
| Q39130428 | Transcriptional Addiction in Cancer. |
| Q59130141 | Transcriptional Profiling of Hypoxia-Regulated Non-coding RNAs in Human Primary Endothelial Cells |
| Q91610618 | Transcriptional control by enhancers and enhancer RNAs |
| Q50119864 | Transcriptional repression in macrophages-basic mechanisms and alterations in metabolic inflammatory diseases. |
| Q61445278 | Transcriptionally induced enhancers in the macrophage immune response to Mycobacterium tuberculosis infection |
| Q38759772 | Understanding super-enhancers |
| Q46486098 | Visualization of Enhancer-Derived Noncoding RNA. |
Search more.